Latest Insider Transactions at Aerie Pharmaceuticals Inc (AERI)
This section provides a real-time view of insider transactions for Aerie Pharmaceuticals Inc (AERI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AERIE PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AERIE PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Julie Mc Hugh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+15.09%
|
-
|
|
Jun 17
2021
|
Benjamin F Mcgraw Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+13.16%
|
-
|
|
Jun 17
2021
|
David W Gryska Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+25.0%
|
-
|
|
Feb 23
2021
|
Vicente Anido Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-0.72%
|
$25,500
$15.66 P/Share
|
|
Feb 23
2021
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-0.12%
|
$4,920
$15.66 P/Share
|
|
Feb 23
2021
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
763
-0.87%
|
$11,445
$15.66 P/Share
|
|
Feb 23
2021
|
Richard J Rubino Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-0.12%
|
$6,150
$15.66 P/Share
|
|
Feb 19
2021
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,542
-3.67%
|
$23,130
$15.95 P/Share
|
|
Feb 15
2021
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
725
-0.27%
|
$11,600
$16.41 P/Share
|
|
Feb 15
2021
|
Casey C. Kopczynski Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,651
+18.59%
|
$0
$0.2 P/Share
|
|
Feb 08
2021
|
Richard J Rubino Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
921
-0.26%
|
$15,657
$17.72 P/Share
|
|
Feb 08
2021
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-1.23%
|
$18,445
$17.72 P/Share
|
|
Feb 08
2021
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
666
-0.32%
|
$11,322
$17.72 P/Share
|
|
Feb 08
2021
|
Vicente Anido Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,500
-1.05%
|
$42,500
$17.72 P/Share
|
|
Feb 07
2021
|
Richard J Rubino Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,075
-0.3%
|
$18,275
$17.68 P/Share
|
|
Feb 07
2021
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-1.37%
|
$20,893
$17.68 P/Share
|
|
Feb 07
2021
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-1.65%
|
$12,002
$17.68 P/Share
|
|
Feb 07
2021
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.34%
|
$11,917
$17.68 P/Share
|
|
Feb 07
2021
|
Vicente Anido Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,496
-1.04%
|
$42,432
$17.68 P/Share
|
|
Feb 06
2021
|
Richard J Rubino Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,185
-0.33%
|
$20,145
$17.68 P/Share
|
|
Feb 06
2021
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,438
-1.58%
|
$24,446
$17.68 P/Share
|
|
Feb 06
2021
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-0.82%
|
$6,001
$17.68 P/Share
|
|
Feb 06
2021
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.42%
|
$14,892
$17.68 P/Share
|
|
Feb 06
2021
|
Vicente Anido Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,958
-1.22%
|
$50,286
$17.68 P/Share
|
|
Feb 04
2021
|
Vicente Anido Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+10.33%
|
-
|
|
Feb 04
2021
|
Richard J Rubino Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+3.25%
|
-
|
|
Feb 04
2021
|
Thomas A Mitro President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+13.3%
|
-
|
|
Feb 04
2021
|
John La Rocca General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+20.36%
|
-
|
|
Feb 04
2021
|
Casey C. Kopczynski Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+5.04%
|
-
|
|
Feb 04
2021
|
David Hollander Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+24.53%
|
-
|
|
Nov 11
2020
|
David Hollander Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-8.65%
|
$28,106
$13.05 P/Share
|
|
Nov 11
2020
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,695
-10.37%
|
$295,035
$13.01 P/Share
|
|
Nov 10
2020
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,305
-3.23%
|
$94,965
$13.0 P/Share
|
|
Feb 27
2020
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-18.1%
|
$17,000,000
$17.07 P/Share
|
|
Dec 20
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
28,900
+1.89%
|
$867,000
$30.0 P/Share
|
|
Dec 03
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
26,600
+1.77%
|
$798,000
$30.0 P/Share
|
|
Nov 26
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
4,400
+0.3%
|
$132,000
$30.0 P/Share
|
|
Nov 15
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
19,900
+1.36%
|
$597,000
$30.0 P/Share
|
|
Nov 14
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
5,700
+0.4%
|
$171,000
$30.0 P/Share
|
|
Nov 07
2019
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
15,000
+1.05%
|
$450,000
$30.0 P/Share
|
|
Sep 05
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,700
+0.66%
|
$282,600
$18.42 P/Share
|
|
Sep 04
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,200
+3.25%
|
$1,803,600
$18.48 P/Share
|
|
Sep 03
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.07%
|
$1,000,000
$21.0 P/Share
|
|
Aug 30
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.09%
|
$525,000
$21.36 P/Share
|
|
Aug 23
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
38,300
+1.67%
|
$880,900
$23.42 P/Share
|
|
Aug 22
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,700
+0.3%
|
$154,100
$23.68 P/Share
|
|
Aug 21
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,153
+0.05%
|
$26,519
$23.25 P/Share
|
|
Aug 20
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+2.22%
|
$1,150,000
$23.21 P/Share
|
|
Aug 19
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,847
+0.18%
|
$88,481
$23.34 P/Share
|
|
Aug 16
2019
|
Foresite Capital Management Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+4.44%
|
$2,400,000
$24.23 P/Share
|